PA-DL6K6-24

General Information


DRACP ID  DRACP01757

Peptide Name   PA-DL6K6-24

Sequence  lKKllKKllKKl

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
22Rv1 Prostate carcinoma Carcinoma LC50<3.125 µM MTT assay Not available Patent
CL1 Prostate carcinoma Carcinoma LC50=3.125 µM MTT assay Not available Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  NIH 3T3: LC50=50 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  CH3(CH2)14CO, Palmitic acid

C-terminal Modification  Amidation

Other Modification  l=D-Leucine

Chiral  Mix



Physicochemical Information


Formula  C36H62N12O

Absent amino acids  ACDEFGHILMNPQRSTVWY

Common amino acids  K

Mass  87534

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  0

Net charge  6

Boman Index  -3330

Hydrophobicity  -195

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US2007/0072808A1

Patent Title  Antimicrobial and anticancer lipopeptides

Other Iinformation  Patent Application; Family: 11s / 13ex; Family Jurisdictions: EP, US, AU, WO, CA; Legal Status: Active; Application No: 56072704; Filed: Jun 18, 2004; Published: Mar 29, 2007; Earliest Priority: Jun 19, 2003; Granted: Mar 2, 2010

Other Published ID  AU2004246909A1  AU2004246909B2  CA2529125A1  EP1633380A2  EP1633380A4  US2010160213A1  US7671011B2  US8445636B2  WO2004110341A2  WO2004110341A3 




DRACP is developed by Dr.Zheng's team.